(Q27864126)

17064357

15 November 2016

title

Distribution, levels and phosphorylation of Raf-1 in Alzheimer's disease (English)

1 reference

PubMed

15 November 2016

1 reference

1 reference

9

Xiongwei Zhu

0 references

Sandra L Siedlak

5

object named as

Sandra L Siedlak

0 references

author name string

Matthew Mei

1

0 references

Mark Chao

4

0 references

Laura A Previll

6

0 references

LaMia Jackson

7

0 references

Kristen Harrison

3

0 references

Dan X Cai

8

0 references

Bo Su

Journal of Neurochemistry

2

0 references

language of work or name

English

0 references

publication date

December 2006

0 references

published in

1 reference

Mechanisms of regulating the Raf kinase family

PubMed

volume

99

0 references

issue

5

0 references

page(s)

1377-88

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04174.X

14-3-3zeta is an effector of tau protein phosphorylation

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04174.X

Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04174.X

Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04174.X

Raf-1 and B-Raf proteins have similar regional distributions but differential subcellular localization in adult rat brain

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04174.X

Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Positive and negative regulation of Raf kinase activity and function by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft für Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Extracellular-signal-regulated kinase signalling in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Dephosphorylation of Ser-259 regulates Raf-1 membrane association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Regulation of Raf-Akt Cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Akt activity in Alzheimer's disease and other neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

The unlabeled antibody method: comparison of peroxidase-antiperoxidase with avidin-biotin complex by a new method of quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Role of serine/threonine protein phosphatase in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

The role of mitogen-activated protein kinase pathways in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Oxidative stress signalling in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Alzheimer's disease: the two-hit hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

Distribution, levels, and activation of MEK1 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04174.X

10.1111/J.1471-4159.2006.04174.X

21 January 2018

Identifiers

DOI

0 references

17064357

1 reference

PubMed

17064357